Isidingo esisha se-Oral COVID-19 Antiviral Medication kanye nokuhlolwa kwegciwane

A BAMBA MahhalaRelease 5 | eTurboNews | eTN
Isithombe sikaLinda Hohnholz
Ibhalwe ngu Linda Hohnholz

Njengamanje, i-COVID-19 isesimeni esiwubhubhane emhlabeni jikelele. Ukuma okuphezulu kwezinhlobonhlobo ze-Delta ne-Omicron kugcwele, okuholela ekuthuthukisweni okuqhubekayo kwekhono lazo lokudlulisela. Phakathi kwamagagasi aphindaphindiwe e-COVID-19, ngaphezu komgomo we-COVID-19, ukuthuthukiswa kwemithi yomlomo esebenzayo ye-COVID-19 kanye nezindlela zokuhlola ezisheshayo, ezilula neziqanjiwe nakho sekube yisidingo esisha sokuvimbela nokulawula ubhubhane lwamanje. I-Viva Biotech Holdings ne-XLement, etshalwe futhi yafakwa yi-Viva BioInnovator, izibophezele ekukhiqizeni izidakamizwa eziphuzwayo ze-COVID-19 kanye nokuhlolwa kwegciwane, okubambe iqhaza ekulweni nobhubhane lwe-COVID-19.

Isivumelwano seLanghua Pharmaceutical ne-MPP sokukhiqiza isithako esingavuthiwe somuthi we-COVID-19 we-antiviral molnupiravir.

Jan 2022, i-Medicines Patent Pool (MPP) yamemezela ukuthi isisayine izivumelwano nezinkampani eziningana ezikhiqiza amajenerikhi okuhlanganisa i-Zhejiang Langhua Pharmaceutical Co., Ltd (Langhua Pharmaceutical), inkampani engaphansi kwe-Viva biotech holdings (Viva Biotech (01873.HK)) ukwenziwa komuthi we-antiviral we-COVID-19 we-molnupiravir futhi uhlinzeke emazweni angu-105 anemali ephansi naphakathi (ama-LMIC) ukuze kube lula ukufinyelela okufinyelelekayo emhlabeni jikelele kwe-molnupiravir futhi kusekelwe ukuvimbela nokulawula ubhubhane lwasekhaya. Izinkampani ezinhlanu zizogxila ekukhiqizeni izithako ezingavuthiwe, izinkampani ezingu-13 zizokhiqiza kokubili isithako esingavuthiwe kanye nomuthi oqediwe kanti izinkampani ezingu-9 zizokhiqiza umuthi osuphelile.

I-Medicines Patent Pool (MPP) yinhlangano yezempilo yomphakathi esekelwa yiZizwe Ezihlangene esebenzela ukukhulisa ukufinyelela, nokwenza lula ukuthuthukiswa kwemithi esindisa impilo yamazwe anemali engenayo ephansi kanye nemaphakathi. I-MPP kanye ne-MSD, igama lokuhweba le-Merck & Co., Inc Kenilworth NJ USA basayine isivumelwano selayisense ngokuzithandela ngo-Oct 2021. Ngaphansi kwemibandela yesivumelwano, i-MPP, ngelayisensi enikezwe yi-MSD, izovunyelwa ukuthi iqhubekisele phambili ilayisensi engakhethekile. amalayisense kubakhiqizi (“Ilayisensi ye-MPP”) futhi kuhlukanise isisekelo sokukhiqiza ukuze kunikezwe i-molnupiravir eqinisekiswe ikhwalithi emazweni ambozwe Ilayisensi ye-MPP, kuncike ekugunyazweni kokulawula kwendawo.

I-Molnupiravir (MK-4482 kanye ne-EIDD-2801) iwuhlobo lophenyo, olulawulwa ngomlomo lwe-analog ye-ribonucleoside enamandla evimbela ukuphindaphinda kwe-SARS-CoV-2 (i-ejenti eyimbangela ye-COVID-19). I-Molnupiravir i-MSD eyakhayo ngokubambisana ne-Ridgeback Biotherapeutics, iwumuthi wokuqala womlomo wokuvimbela amagciwane otholakalayo wokwelapha i-COVID-19. Idatha evela kuSigaba 3 I-MOVe-OUT ibonise ukuthi ukwelashwa kusenesikhathi nge-molnupiravir kwehlisa kakhulu ingcuphe yokulaliswa esibhedlela noma yokushona engozini enkulu, abantu abadala abangagonyiwe abane-COVID-19.

Ngokusho kwe-MPP, izinkampani ezanikezwa amalayisense amancane zabonisa ngempumelelo amandla azo okuhlangabezana nezidingo ze-MPP ezihlobene namandla okukhiqiza, ukuthobela imithetho, kanye nekhono lokuhlangabezana namazinga omhlaba emithi eqinisekiswa yikhwalithi. Ukugunyazwa okunikezwe i-Langhua Pharmaceutical yi-MPP kumele ukuqinisekiswa okuphezulu nokuqashelwa ekuthuthukisweni kwenqubo yayo kanye nokukhulisa ama-API, ukusimama kokuhlinzeka, i-GMP kanye nohlelo lwe-EHS.

Ikhithi Yokuhlola ye-Xlement's COVID-19 Iphumelele Ukuhlolwa Komnyango Wesayensi Nobuchwepheshe wasePeople's Republic of China

Ngomhla zi-2 kuNdasa, 2022, u-Xlement, inkampani ezinikele ye-NanoSPR biochip kanye nezinsimbi ze-biotech eyatshala imali ngaphambilini futhi yafukanyelwa yi-Viva BioInnovator, yathola isaziso sokudlulisa ukuhlolwa kokusebenza ku-Ministry of Science and Technology of the People's Republic of China. Iphrojekthi yayo ethi “R&D and Mass Production ye-NanoSPR COVID-19 Particle Test Kit” ingenye yamaphrojekthi abalulekile “wohlelo Lokuvinjelwa Nokulawulwa Kwengozi Yezokuphepha Komphakathi kanye Nobuchwepheshe Bezimo Eziphuthumayo Nezisetshenziswa” olunikeza ingxenye ebalulekile ku-COVID-19- ucwaningo lwesayensi oluhlobene oluqhubekayo eShayina. Ngokuphumelela kwayo ekuhlolweni, Ikhithi Yokuhlola ye-Xlement's COVID-19 nayo isigunyazwe yi-European Union CE ukuze ikhiqize ngobuningi besikhathi esizayo futhi izoqala ukusetshenziswa maduze.

Isebenzisa ubuchwepheshe be-chip ye-NanoSPR obuyingqayizivele, i-Xlement ithuthukise ikhithi yokuhlola yezinhlayiya ze-COVID-19, evumela ukuhlolwa kwesinyathelo esisodwa sama-antigen amaningi amagciwane kumasampula angama-96 kungakapheli imizuzu eyi-15, futhi ukuzwela kuseduze nokuhlola i-antigen eyodwa. Le ndlela ibonisa izinzuzo ezinkulu uma kuqhathaniswa namasu okuhlola i-viral nucleic acid ekhona: ingasetshenziselwa ukuzihlola ekhaya, inciphisa isikhathi sokuhlola ngokuphawulekayo, ngaleyo ndlela, inciphisa kakhulu izindleko zokuhlola ama-reagents kanye nomsebenzi. Ngokwamukelwa okwengeziwe kobuchwepheshe be-NanoSPR ekuhlolweni kwe-COVID-19 okuthuthukiswe yi-Xlement, silindele ukubona ukuxilongwa okushesha kakhudlwana kwamasampuli asolwayo kanye nokuhlolwa ngokushesha esizeni ngezinga elikhulu.

Mayelana umbhali

Isithombe sikaLinda Hohnholz

Linda Hohnholz

Umhleli omkhulu we eTurboNews ezinze eTN HQ.

Bhalisa
Yazisa ngakho
isivakashi
0 Amazwana
Okungaphakathi Okuphakelayo
Buka wonke amazwana
0
Ungathanda imibono yakho, ngicela uphawule.x
Yabelana ku...